Lipid signatures of chronic pain in female adolescents with and without obesity

Table 1 Demographic and anthropomorphic data

	Healthy Controls	Pain/Healthy Weight	Obese Alone	Pain & Obese	P-value
N	17	17	16	17
Age (years)	14.8 [1.3]	15.5 [1.2]	14.7 [1.6]	15.1 [1.4]	> 0.32
Race					0.23
White	15	16	12	11
African-American	0	1	0	2
Native American	0	0	0	1
More than 1	2	0	4	3
Hispanic					> 0.60
No	16	13	13	14
Yes	1	3	3	3
No answer	0	1	0	0
BMI (percentile)	55 [41–70]	54 [38–73]	97 [95–98]*	98 [96–99]*	< 0.001
Pain Location (n, %)					> 0.06
Headache/Migraine		10 (58.8)		15 (88.2)
Extremities		3 (17.6)		0
Abdomen		1 (5.9)		2 (11.8)
Other		3 (17.6)		0 (0.0)
Pain Duration (months)		24 [18–30]		24 [8–60]	> 0.18
PFSD1 (days)	1.0 [0.0–2.0]	13.0 [5.5–14.0]**	1.0 [0.0–3.0]	7.0 [3.5–13.0]**	< 0.001
PFSD4 (worst pain intensity)					< 0.001
	0.0 [0.0–5.0]	8.0 [7.0–9.5]**	0.0 [0.0–6.0]	8.0 [5.0–8.0]**

Data are shown as mean [SD] or median [25th–75th %] where appropriate
BMI Body mass index, PFSD1 Pain Frequency Severity Duration Scale-1 (PFSD1; days with pain in the past 2 weeks), Pain Frequency Severity Duration Scale-4 (PFSD4; worst pain intensity in the past 2 weeks)
*different from Healthy Controls and Pain/Healthy Weight groups (P < 0.001)
**different from Healthy Controls and Obese Alone groups (P range, 0.003 to < 0.001)

ISSN: 1476-511X